Adan Medical develops a digital platform that integrates telemonitoring and data analytics to enhance the management of anaphylaxis, ensuring that patients have access to adrenaline autoinjectors in optimal condition. The solution addresses the rising prevalence of severe allergic reactions by improving adherence to treatment protocols and providing real-time stock management for healthcare providers.

Anaconda Biomed develops a catheter system designed for mechanical thrombectomies, utilizing a nitinol braided funnel to enhance clot retention and minimize fragmentation during retrieval. This technology addresses the critical need for effective stroke intervention by improving the efficiency and safety of clot removal in patients with acute ischemic stroke.

Aortyx develops bioresorbable endovascular devices that mimic the biomechanical environment of the aorta to promote tissue regeneration in patients with aortic diseases. Their technology facilitates cell migration and proliferation, addressing the limitations of traditional vascular treatments.

The startup develops clinically validated virtual reality therapeutic devices that provide on-demand, all-in-one platforms for managing acute and chronic pain. These devices enhance clinical outcomes for patients with serious health conditions by offering targeted pain relief solutions.

Corify Care has developed ACORYS®, a non-invasive cardiac mapping system that enables clinicians to perform real-time, beat-to-beat global cardiac mapping in under 10 minutes. This technology addresses the limitations of traditional catheter-based mapping by providing a comprehensive view of the entire heart, enhancing diagnostic accuracy and patient safety.

The startup manufactures cyanoacrylate adhesives specifically formulated for medical, veterinary, and cosmetic applications, providing effective wound closure and skin treatment solutions. Their products enable low-cost, efficient suturing of wounds and lacerations, enhancing patient care and recovery outcomes.

Fecundis develops sperm-enhancing technologies that improve sperm functionality and increase embryo quality, based on over 20 years of research in reproductive biology. The company addresses the inefficiencies and challenges of traditional fertility treatments by providing scalable solutions that integrate into clinical workflows.

Frontwave Imaging develops software as a medical device (SaMD) that generates high-resolution 3D ultrasound images of the breast for improved diagnostics. The service encompasses data transfer to the cloud, image reconstruction, and analysis through a user-friendly interface. This solution enables safer, more frequent monitoring of tumor progression compared to existing screening methodologies.

Gro develops autonomous protocols for decentralized finance (DeFi) that simplify user interactions and enhance accessibility. By streamlining complex transactions, Gro addresses the barriers to entry for users unfamiliar with traditional DeFi platforms.

HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.

Labs develops human-enhancement technologies that utilize artificial intelligence, immersive realities, and consumer-wearables to foster community engagement and improve individual capabilities. The company addresses the need for interconnected social experiences and sustainable practices by providing tools that empower users to learn, create, and collaborate effectively.

This company provides data-driven technology solutions to empower healthcare delivery across Africa. Their platform enables patients to engage with doctors and manage health records securely within a single application. Health facilities utilize the system for efficient patient management and data-driven revenue growth, while global organizations gain access to real-time health data.

OLI is developing decentralized home hemodialysis devices that enable patients to manage kidney disease treatment in their own homes. This technology addresses the limitations of traditional in-center dialysis by providing greater accessibility and convenience for patients, ultimately improving their quality of life.

Om provides access to massive, internally generated datasets detailing proteome-wide small molecule binding data. Researchers can programmatically query billions of protein and small molecule interaction data points to identify therapeutic opportunities instantly. The platform leverages synthetic biology and pico-scale engineering to accelerate the transition from hypothesis to launching a discovery program.

ProCure Health delivers mobile wound care services to patients in their homes or other care facilities, offering treatment for chronic wounds. Their network of wound care practitioners accepts referrals from various healthcare providers and specialists, ensuring patients receive timely and convenient access to advanced wound care.

The startup provides a global transaction layer for insurable risk services that evaluates insurance premiums and underwrites risks, enabling insurers and reinsurers to optimize their return on equity. By offering a future-oriented reinsurance partnership, the company enhances program profitability and supports long-term capital growth for policyholders.

RemAb Therapeutics develops synthetic polymeric conjugates that selectively bind to and facilitate the rapid clearance of harmful antibodies from circulation, addressing issues related to infectious diseases, autoimmunity, and blood group incompatibility. This targeted removal technology provides patients with immediate clinical benefits by mitigating adverse immune responses.

Rethink Medical is developing the T-Control® urinary catheter, which incorporates three additional functions to enhance patient comfort and reduce the risk of catheter-related urinary infections. This device addresses the challenges faced by nursing staff in managing continence care, ultimately improving healthcare efficiency as the demand for such solutions increases with an aging population.

Ro operates a telehealth platform that provides online clinics for weight loss, sexual health, hair restoration, and fertility management using clinically proven treatments and prescription medications. The service eliminates the need for insurance and offers free, discreet shipping, making healthcare accessible and convenient for over 2 million members.

The startup develops a medical device that enhances infant stability and comfort during spinal tap procedures by maintaining an upright position for optimal access to the spinal fluid column. Utilizing ultrasound data, the device significantly increases interspinous space, facilitating more effective treatment by healthcare professionals.

Swan provides a Banking-as-a-Service platform that enables companies to integrate white-labeled banking features, such as accounts, cards, and payments, directly into their products through APIs. This approach eliminates the complexities of regulatory compliance and financial infrastructure, allowing businesses to enhance their customer experience and create new revenue streams without the burden of managing banking operations.

tem. provides businesses with a platform to purchase 100% renewable energy directly from generators, reducing energy costs by an average of 25% while ensuring full traceability of energy sources. By eliminating intermediary fees, tem. facilitates a more transparent and cost-effective energy transition for companies committed to sustainability.

The startup develops automated AI tools that enhance the sensitivity and specificity of lesion detection in magnetic resonance imaging. By providing neuroradiologists with machine intelligence capabilities, the tools minimize errors in visual assessments, ultimately improving patient care for those with multiple sclerosis.

Tru utilizes Achievement DNA analysis to provide organizations with deep insights into individual strengths and fulfillment, enabling better alignment of employees with roles that maximize their potential. This approach addresses low employee engagement and retention by fostering a work environment that enhances performance and satisfaction.